30 Apr 2019
The board has proposed a rights issue to start addressing large markets in diabetes and oncology care. We see signs of increased growth and news flow as supportive for the shares.
Read the full report (Swedish) here.
Wir verwenden Cookies, um Ihnen das bestmögliche Erlebnis unserer Website zu bieten Mehr Infos
Akzeptieren